These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20229604)

  • 61. An examination of protein binding and protein-facilitated uptake relating to in vitro-in vivo extrapolation.
    Bowman CM; Benet LZ
    Eur J Pharm Sci; 2018 Oct; 123():502-514. PubMed ID: 30098391
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Discovery of Spiro Oxazolidinediones as Selective, Orally Bioavailable Inhibitors of p300/CBP Histone Acetyltransferases.
    Michaelides MR; Kluge A; Patane M; Van Drie JH; Wang C; Hansen TM; Risi RM; Mantei R; Hertel C; Karukurichi K; Nesterov A; McElligott D; de Vries P; Langston JW; Cole PA; Marmorstein R; Liu H; Lasko L; Bromberg KD; Lai A; Kesicki EA
    ACS Med Chem Lett; 2018 Jan; 9(1):28-33. PubMed ID: 29348807
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol.
    Obach RS
    Drug Metab Dispos; 1997 Dec; 25(12):1359-69. PubMed ID: 9394025
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Direct determination of the ratio of unbound fraction in plasma to unbound fraction in microsomal system (fu p/fu mic) for refined prediction of phase I mediated metabolic hepatic clearance.
    Deshmukh SV; Harsch A
    J Pharmacol Toxicol Methods; 2011; 63(1):35-9. PubMed ID: 20433934
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties.
    Austin RP; Barton P; Cockroft SL; Wenlock MC; Riley RJ
    Drug Metab Dispos; 2002 Dec; 30(12):1497-503. PubMed ID: 12433825
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Application of the fluorescent probe 1-anilinonaphthalene-8-sulfonate to the measurement of the nonspecific binding of drugs to human liver microsomes.
    McLure JA; Birkett DJ; Elliot DJ; Williams JA; Rowland A; Miners JO
    Drug Metab Dispos; 2011 Sep; 39(9):1711-7. PubMed ID: 21610127
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Microsome composition-based model as a mechanistic tool to predict nonspecific binding of drugs in liver microsomes.
    Poulin P; Haddad S
    J Pharm Sci; 2011 Oct; 100(10):4501-17. PubMed ID: 21574165
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lack of appreciable species differences in nonspecific microsomal binding.
    Zhang Y; Yao L; Lin J; Gao H; Wilson TC; Giragossian C
    J Pharm Sci; 2010 Aug; 99(8):3620-7. PubMed ID: 20229604
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Investigation of the utility of published in vitro intrinsic clearance data for prediction of in vivo clearance.
    Nagilla R; Frank KA; Jolivette LJ; Ward KW
    J Pharmacol Toxicol Methods; 2006; 53(2):106-16. PubMed ID: 16188462
    [TBL] [Abstract][Full Text] [Related]  

  • 70.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 71.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.